NTRK1 and non-small cell lung carcinoma: The receptor tyrosine kinase ROS proto-oncogene 1 (ROS1) belongs to a group of receptor tyrosine kinases in the insulin family of receptors, and ROS1 rearrangements are observed in approximately 1%–2% of patients with NSCLC (Gainor and Shaw, 2013).